Myxomatous atrioventricular valve disease: how to diagnose, monitoring disease progression, when to treat

2018 ◽  
pp. 34-34
Author(s):  
Mark Oyama
2017 ◽  
Vol 115 (3) ◽  
pp. E363-E371 ◽  
Author(s):  
Ana M. Porras ◽  
Jennifer A. Westlund ◽  
Austin D. Evans ◽  
Kristyn S. Masters

An insufficient understanding of calcific aortic valve disease (CAVD) pathogenesis remains a major obstacle in developing treatment strategies for this disease. The aim of the present study was to create engineered environments that mimic the earliest known features of CAVD and apply this in vitro platform to decipher relationships relevant to early valve lesion pathobiology. Glycosaminoglycan (GAG) enrichment is a dominant hallmark of early CAVD, but culture of valvular interstitial cells (VICs) in biomaterial environments containing pathological amounts of hyaluronic acid (HA) or chondroitin sulfate (CS) did not directly increase indicators of disease progression such as VIC activation or inflammatory cytokine production. However, HA-enriched matrices increased production of vascular endothelial growth factor (VEGF), while matrices displaying pathological levels of CS were effective at retaining lipoproteins, whose deposition is also found in early CAVD. Retained oxidized low-density lipoprotein (oxLDL), in turn, stimulated myofibroblastic VIC differentiation and secretion of numerous inflammatory cytokines. OxLDL also increased VIC deposition of GAGs, thereby creating a positive feedback loop to further enrich GAG content and promote disease progression. Using this disease-inspired in vitro platform, we were able to model a complex, multistep pathological sequence, with our findings suggesting distinct roles for individual GAGs in outcomes related to valve lesion progression, as well as key differences in cell–lipoprotein interactions compared with atherosclerosis. We propose a pathogenesis cascade that may be relevant to understanding early CAVD and envision the extension of such models to investigate other tissue pathologies or test pharmacological treatments.


2013 ◽  
Vol 33 (suppl_1) ◽  
Author(s):  
Amy M Opoka ◽  
Amy L Juraszek ◽  
Hanna Osinska ◽  
J Michael Smith ◽  
Walter H Merrill ◽  
...  

Introduction Elastic fiber fragmentation (EFF) is a hallmark of aortic valve disease (AVD), and both inflammation and neovascularization have been identified as late findings, presumably due to atherosclerosis through a wound healing like response. However, EFF independently stimulates angiogenesis, suggesting an alternative mechanism for neovascularization in AVD. Hypothesis We hypothesized that aberrant angiogenesis would be an early AVD finding, preceding inflammation, due to EFF. Methods To examine disease progression, valve tissue was examined using histochemistry and immunohistochemistry from early (<40yo) and late (≥40yo) onset AVD specimens, as well as age-matched autopsy control aortic valves. Angiogenesis (VEGF-A, CD-31, SMA and chondromodulin), EFF (elastin, fibrillin-1, emilin-1, fibulin-5), progenitor valve interstitial cell phenotype (CD-34, CD-45) and inflammation (CD-68, LRP-5) were assessed. Results Bicuspid aortic valve was more common in early-onset AVD (n=21), and cardiovascular comorbidities were more common in late-onset AVD (n=11). Early-onset AVD specimens demonstrated angiogenesis without inflammation or atherosclerosis. A distinct pattern of EFF and elastic fiber components surrounded early-onset AVD neovessels, which were not present in control valves, including increased emilin and decreased fibulin-5, and the elastase/anti-elastase ratio and localization were altered in both early and late-onset AVD, suggesting a dynamic disease progression. Interestingly, progenitor VICs were present in control valves at both stages and were unchanged in age-matched AVD specimens. Conclusions Aberrant angiogenesis is an early mechanism in AVD pathogenesis preceding inflammation, implicating EFF as an inciting factor. Elucidation of the underlying mechanisms may inform the development of new pharmacologic therapeutics and durable bioprostheses.


Author(s):  
Stephen Biddle ◽  
Clara Seaman ◽  
Philippe Sucosky

Calcific aortic valve disease (CAVD) is the most prevalent heart valve disease in the U.S. and is characterized by the formation of calcific lesions within the valve leaflets [1]. The emerging hemodynamic theory of CAVD pathogenesis assumes a link between gradual hemodynamic alterations caused by the growing lesions and further disease progression [2–5]. In order to test this hypothesis, it is necessary to quantify the hemodynamic changes experienced downstream of a calcifying valve.


Heart ◽  
2014 ◽  
Vol 100 (10) ◽  
pp. 800-805 ◽  
Author(s):  
Onn Akbar Ali ◽  
Matthew Chapman ◽  
Thanh Ha Nguyen ◽  
Yuliy Y Chirkov ◽  
Tamila Heresztyn ◽  
...  

2017 ◽  
Vol 33 (2) ◽  
pp. 156-162
Author(s):  
Naoki Yoshimura ◽  
Yuki Ikeno

Sign in / Sign up

Export Citation Format

Share Document